Exicure, Inc.

UEI
DHJTJ8VK9KC9
CAGE
6GGR1
Primary NAICS
541711 Research and Development in Biotechnology
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
R & d entitled, "genetically programmable spherical nucleic acids as rapidly adaptable nanotherapeutics". W911QX13C0070 Defense Contract Management Agency $1,275,796
DARPA sbir phase i genetically programmable spherical nucleic acids as rapidly adaptable nanotherapeutics W911QX12C0073 ACC Aberdeen Proving Ground $149,295

Grant awards

Award Agency Obligated Awarded
Topically-delivered targeted gene suppression of immune activation in psoriasis R41AR066438 National Institutes of Health $149,941
Topically-delivered mutation-specific gene targeting for epidermolytic ichthyosis R43AR066387 National Institutes of Health $224,935

Quick answers

Is Exicure, Inc. registered in SAM.gov?

Exicure, Inc.'s SAM.gov registration expired on February 11, 2023.

What is Exicure, Inc.'s most recent federal award?

Exicure, Inc.'s most recent federal grant award is Topically-delivered targeted gene suppression of immune activation in psoriasis (R41AR066438), from National Institutes of Health, on September 1, 2014.

On GovTribe

See Exicure, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login